NBI-827104
NBI-827104-CSWS2025
Phase 2 small_molecule terminated
Quick answer
NBI-827104 for Epileptic Encephalopathy is a Phase 2 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Epileptic Encephalopathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated